| Patient-derived xenograft (PDX) models in basic and translational breast cancer research LE Dobrolecki, SD Airhart, DG Alferez, S Aparicio, F Behbod, ... Cancer and Metastasis Reviews 35, 547-573, 2016 | 252 | 2016 |
| Progesterone/RANKL is a major regulatory axis in the human breast T Tanos, G Sflomos, PC Echeverria, A Ayyanan, M Gutierrez, JF Delaloye, ... Science translational medicine 5 (182), 182ra55-182ra55, 2013 | 212 | 2013 |
| A preclinical model for ERα-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response G Sflomos, V Dormoy, T Metsalu, R Jeitziner, L Battista, V Scabia, ... Cancer cell 29 (3), 407-422, 2016 | 198 | 2016 |
| Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity EMBO Mol Med . 11908, 2020 | 97 | 2020 |
| Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor V Scabia, A Ayyanan, F De Martino, A Agnoletto, L Battista, C Laszlo, ... Nature Communications 13 (1), 3127, 2022 | 64 | 2022 |
| The histone chaperone SET/TAF-Iβ interacts functionally with the CREB-binding protein Z Karetsou, G Martic, G Sflomos, T Papamarcaki Biochemical and Biophysical Research Communications 335 (2), 322-327, 2005 | 46 | 2005 |
| The challenges of modeling hormone receptor-positive breast cancer in mice BC Özdemir, G Sflomos, C Brisken Endocrine-related cancer 25 (5), R319-R330, 2018 | 42 | 2018 |
| SARA and RNF11 interact with each other and ESCRT-0 core proteins and regulate degradative EGFR trafficking E Kostaras, G Sflomos, NM Pedersen, H Stenmark, T Fotsis, C Murphy Oncogene 32 (44), 5220-5232, 2013 | 36 | 2013 |
| ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN G Sflomos, E Kostaras, E Panopoulou, N Pappas, A Kyrkou, AS Politou, ... Journal of cell science 124 (19), 3209-3222, 2011 | 36 | 2011 |
| Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium S Cagnet, D Ataca, G Sflomos, P Aouad, S Schuepbach-Mallepell, ... Nature communications 9 (1), 4723, 2018 | 35 | 2018 |
| Intraductal patient‐derived xenografts of estrogen receptor α‐positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions M Fiche, V Scabia, P Aouad, L Battista, A Treboux, A Stravodimou, ... The Journal of pathology 247 (3), 287-292, 2019 | 34 | 2019 |
| Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1 G Sflomos, L Battista, P Aouad, F De Martino, V Scabia, A Stravodimou, ... EMBO Molecular Medicine 13 (3), e13180, 2021 | 32 | 2021 |
| Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence P Aouad, Y Zhang, F De Martino, C Stibolt, S Ali, G Ambrosini, SA Mani, ... Nature communications 13 (1), 4975, 2022 | 24* | 2022 |
| Atlas of lobular breast cancer models: challenges and strategic directions G Sflomos, K Schipper, T Koorman, A Fitzpatrick, S Oesterreich, AV Lee, ... Cancers 13 (21), 5396, 2021 | 23 | 2021 |
| Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation M Shamseddin, F De Martino, C Constantin, V Scabia, AS Lancelot, ... EMBO Molecular Medicine 13 (7), e14314, 2021 | 23 | 2021 |
| A novel culture method that sustains ERα signaling in human breast cancer tissue microstructures AL Cartaxo, MF Estrada, G Domenici, R Roque, F Silva, EJ Gualda, ... Journal of Experimental & Clinical Cancer Research 39, 1-14, 2020 | 20 | 2020 |
| An ex vivo model to study hormone action in the human breast G Sflomos, M Shamseddin, C Brisken JoVE (Journal of Visualized Experiments), e52436, 2015 | 8 | 2015 |
| A new Achilles Heel in breast cancer? G Sflomos, C Brisken Oncotarget 4 (8), 1126, 2013 | 8 | 2013 |
| Breast Cancer Microenvironment and the Metastatic Process G Sflomos, C Brisken Breast Cancer, pp.39-48, 2017 | 4 | 2017 |
| Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer M Bacci, N Lorito, A Smiriglia, A Subbiani, F Bonechi, G Comito, ... Science Translational Medicine 16 (736), eadf9874, 2024 | 1 | 2024 |
Cathrin BriskenVerified email at epfl.ch
